CareDx, Inc.

CDNA Healthcare Diagnostics & Research

CareDx, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $379.8 million, up 13.8% from fiscal 2024. In the quarter to June 2026, revenue grew 52.2%, EPS grew 1,443.8% and free cash flow grew 223.4%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

63.81 2.87 −4.30%
Market cap
$3.5B
P/E
29.7×
Fwd P/E
2,967×
Dividend yield
—
F-score
5/9
Altman Z
4.14
Beneish M
−3.36
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
13.26 0.00 0.00 11.18

+8 more quarters

P/S ratio
3.20 2.15 2.64 2.13
P/FCF ratio
17.64 14.03 29.06 21.49
P/Operating CF
47.93 204.94 46.99 20.44
P/B ratio
3.45 2.83 3.31 2.45
EV/Sales
2.39 1.70 2.18 1.60
EV/EBITDA
8.43 118.53 0.00 6.91
EV/FCF
13.18 11.11 24.00 16.09
Current Ratio
4.58 3.40 2.86 3.03
Net Debt/EBITDA
(3.17) (25.20) 54.39 (23.96)
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
7.54% (0.92%) (2.12%) 8.94%
Free Cash Flow Yield
5.67% 7.13% 3.44% 4.65%
Free Cash Flow per Share
0.56 0.01 0.36 0.67
Book value per Share
8.27 6.13 5.69 5.93
Free Cash Flow
28.75 0.51 19.39 35.38
EV/EBIT
10.13 0.00 0.00 9.59
Other line items

Show all line items

Columns are period end dates